Nurix Therapeutics Inc. (NASDAQ: NRIX) presented preclinical data on multiple oncology programs at the American Association for Cancer Research Annual ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE